Carcinoma, Non-Small-Cell Lung: all 6,645 studies
Page 51 of 67. Open to participants first (1,667), then studies with results posted, then the rest; newest registration first within each.
- Biomarker Study Accompanying the AIO-TRK-0114 Study (MARBLE)TerminatedNCT02595840Phase 2
- Safety & Immunogenicity of JNJ-64041757, Live-attenuated Double-deleted Listeria Immunotherapy, in Subjects With Non Small Cell Lung CancerTerminatedNCT02592967Phase 1
- MAGE A10ᶜ⁷⁹⁶T for Advanced NSCLCCompletedNCT02592577Phase 1
- A Clinical Trial of Fruquintinib in Patients With Advanced Non-small Cell Lung CancerCompletedNCT02590965Phase 2
- Study of Stereotactic Ablative Radiotherapy (SABR) in Elderly Stage I NSCLCStatus unknownNCT02584699Phase 2
- A Study of AZD2014 in Combination With Selumetinib in Patients With Advanced CancersStatus unknownNCT02583542Phase 1/2
- ONO-4538 Study in Patients With Advanced Non-Small Cell Lung CancerCompletedNCT02582125Phase 2
- Phase 1/2 Study of the Safety and Efficacy of Rociletinib in Combination With Trametinib in Patients With mEGFR-positive Advanced or Metastatic Non-small Cell Lung CancerTerminatedNCT02580708Phase 1/2
- Systemic Chemotherapy Combined With Recombinant Human Adenovirus Type 5 and Endostatin Injections for Treatment Malignant Hydrothorax in NSCLC PatientsStatus unknownNCT02579564Phase 3
- A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid TumorsCompletedNCT02576431Phase 2
- Weekly Use First-generation EGFR-TKI in the Treatment of EGFR-TKI Acquired Resistance Non-small Cell Lung Cancer (NSCLC)CompletedNCT02575560
- GR-MD-02 Plus Pembrolizumab in Melanoma, Non-small Cell Lung Cancer, and Squamous Cell Head and Neck Cancer PatientsCompletedNCT02575404Phase 1
- Study of Split-course Chemoradiotherapy For Locally Advanced None-small Cell Lung CancerCompletedNCT02573506Phase 2
- ENB Robotic ICG Guided Surgery: A Novel Technique for Targeting Small Lung TumorsWithdrawnNCT02570958Phase 1
- Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)Active, not recruitingNCT02568267Phase 2
- Talazoparib in Treating Patients With Advanced or Metastatic Solid Tumors That Cannot Be Removed by Surgery and Liver or Kidney DysfunctionWithdrawnNCT02567396Phase 1
- Genomic Sequencing in Determining Treatment in Patients With Metastatic Cancer or Cancer That Cannot Be Removed by SurgeryTerminatedNCT02566421Not applicable
- Study of Pembrolizumab Maintenance Following First-Line Platinum Based Chemotherapy in Patients With Metastatic Squamous - Non-Small Cell Lung Cancer (sNSCLC)TerminatedNCT02564380Phase 2
- SBRT (Stereotactic Body Radiation Therapy) vs. Surgery in High Risk Patients With Early Stage Lung CancerCompletedNCT02562027Not applicable
- Improving Clinical Trial Awareness in NSCLC: Pilot Testing A Novel Healthcare IT Platform for Incorporating Education at the Point of CareCompletedNCT02558998Not applicable
- IMRT Combined With Erlotinib for EGFR Wild Type Non-small Cell Lung Cancer With 4-10 Brain MetastasesTerminatedNCT02556593Phase 2
- Metronomic Chemotherapy Based on Adaptative Bio-mathematical Model of Oral Vinorelbine in Patients With NSCLC or MPMCompletedNCT02555007Phase 1
- Genomic Landscape of CeritinibTerminatedNCT02554591
- Nimotuzumab in Combination With Radiochemotherapy for Patients With Stage IIIA/IIIB Non-small Cell Lung CancerStatus unknownNCT02549261Not applicable
- Rociletinib (CO-1686) USA Expanded Access ProgramNo longer availableNCT02547675
- Abscopal Effect for Metastatic Non-small Cell Lung Cancer.WithdrawnNCT02542930Phase 2
- Study of Apatinib in RET Fusion Positive Advanced Non-small Cell Lung CancerStatus unknownNCT02540824Phase 2
- Phase II Trial of EP4 Receptor Antagonist, AAT-007 (RQ-07; CJ-023,423) in Advanced Solid TumorsWithdrawnNCT02538432Phase 2
- Talazoparib in Combination With Gemcitabine and Cisplatin in Patients With Advanced Solid TumorsWithdrawnNCT02537561Phase 1
- Efficacy and Safety of Pyrotinib in Patients With HER2 Mutation Advanced Non-Small Cell Lung CancerStatus unknownNCT02535507Phase 2
- A Study of Pemetrexed Maintenance With or Without ADXS11-001 Immunotherapy in Patients With Human Papillomavirus Positive (HPV+), NSCLC Following First-Line Induction ChemotherapyWithdrawnNCT02531854Phase 2
- Gefitinib for EGFR Sensitive Mutation Postoperative Stage Ib NSCLC PatientsTerminatedNCT02526537
- MPDL3280A With Chemoradiation for Lung CancerActive, not recruitingNCT02525757Phase 2
- An Open-label Phase Ib/II Study of BAY 1000394 (Roniciclib) in Combination With Docetaxel in Second- or Third-line Treatment of Patients With Advanced Non-small Cell Lung Cancer (NSCLC)WithdrawnNCT02522910Phase 1/2
- Osimertinib and Navitoclax in Treating Patients With EGFR-Positive Previously Treated Advanced or Metastatic Non-small Cell Lung CancerCompletedNCT02520778Phase 1
- Role of FDG PET, Immune and Hypoxic Marker in NSCLCCompletedNCT02519062
- Tumor-specific T Cells in Lung CancerActive, not recruitingNCT02515760Not applicable
- The Efficacy and Safety of Apatinib in Heavily Pretreated Advanced Non-squamous Non-small Cell Lung CancerStatus unknownNCT02515435Phase 2
- Endostar Treatment of Advanced Non-small Cell Lung Cancer Multi-center Clinical ResearchStatus unknownNCT02513355Phase 4
- Role of PET Scan in the Evaluation of Early Response to Maintenance Treatment in Advanced Non-small-cell Lung CancerStatus unknownNCT02507518Phase 2
- Testing the Combination of MLN0128 (TAK-228) and AZD9291 in Advanced EGFR (Epidermal Growth Factor Receptor) Mutation Positive Non-small Cell Lung CancerActive, not recruitingNCT02503722Phase 1
- Selumetinib and Paclitaxel as Second-Line Treatment in Treating Patients With Stage IIIB-IV Non-small Cell Lung CancerCompletedNCT02503358Phase 1
- A Study of ASP8273 in Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor-Naïve Patients With Non-Small Cell Lung Cancer Harboring EGFR MutationsTerminatedNCT02500927Phase 2
- Crizotinib in Pretreated Metastatic Non-small-cell Lung Cancer With MET Amplification or ROS1 Translocation (METROS)Status unknownNCT02499614Phase 2
- Recombinant Human Endostatin Combined With NP in Neoadjuvant Chemotherapy of Stage ⅢA NSCLCCompletedNCT02497118Phase 4
- Osimertinib and Necitumumab in Treating Patients With EGFR-Mutant Stage IV or Recurrent Non-small Cell Lung Cancer Who Have Progressed on a Previous EGFR Tyrosine Kinase InhibitorActive, not recruitingNCT02496663Phase 1
- Recombinant EphB4-HSA Fusion Protein With Standard Chemotherapy Regimens in Treating Patients With Advanced or Metastatic Solid TumorsActive, not recruitingNCT02495896Phase 1
- Phase 2 Study of MPDL3280A Combined With CDX-1401 in NY-ESO 1 (+) IIIB, IV or Recurrent Non-Small Cell Lung CancerWithdrawnNCT02495636Phase 2
- Pembrolizumab After SBRT Versus Pembrolizumab Alone in Advanced NSCLCCompletedNCT02492568Phase 2
- Afatinib Genomic LandscapeTerminatedNCT02491775
- Comparative Study of the Hypoxia Measured in FAZA and F-miso PET/CT Scan in Patients With Non-small Cell Lung CancerCompletedNCT02490696Phase 2
- Determination of Peripheral Immune Cell Activity During Treatment With Either Surgery or Radiotherapy in Patients With Early Stage NSCLCCompletedNCT02488850Not applicable
- Maintaining ERBB Blockade in EGFR-mutated Lung CancerTerminatedNCT02488694Phase 2
- Icotinib in Advanced Metastatic Patients With NSCLC Previously Treated With ChemotherapyCompletedNCT02486354Phase 3
- Phase II Trial of HM61713 for the Treatment of ≥2nd Line T790M Mutation Positive Adenocarcinoma of the LungTerminatedNCT02485652Phase 2
- Comparison of Lobectomy and Segmentectomy for cT1aN0M0 Peripheral NSCLCStatus unknownNCT02481661Phase 3
- Zoledronic Acid Combined Radiotherapy for Bone Metastasis of Non-small Cell Lung CancerStatus unknownNCT02480634Phase 4
- Survey on the Treatment Reality of Patients With Epidermal Growth Factor Receptor (EGFR) Mutation-positive Non-small Cell Lung Cancer(NSCLC)CompletedNCT02475720
- Expanded Access Program With Nivolumab Therapy for Treatment of Advanced/Metastatic SqNSCLC or Non-SqNSCLC After One Prior Systemic RegimenNo longer availableNCT02475382
- Study of Interest of Personalized Radiotherapy Dose Redistribution in Patients With Stage III NSCLCCompletedNCT02473133Phase 2
- Neoadjuvant Afatinib in Early Stage Non Small Cell Lung Cancer.SuspendedNCT02470065Phase 2
- A Safety and Efficacy Study of INC280 Alone, and in Combination With Erlotinib, Compared to Chemotherapy, in Advanced/Metastatic Non-small Cell Lung Cancer Patients With EGFR Mutation and cMET AmplificationTerminatedNCT02468661Phase 1
- Study Evaluating Hemay020 In Subjects With Advanced Solid CancerTerminatedNCT02467569Phase 1
- A Pilot Study of MPDL3280A and HIGRT in Metastatic NSCLCCompletedNCT02463994Early Phase 1
- Multiple-portal VATS Versus Uniportal VATS Lobectomy for Non-small Cell Lung CancerStatus unknownNCT02462356Not applicable
- Immunotherapy Combination Study in Advanced Previously Treated Non-Small Cell Lung CancerTerminatedNCT02460367Phase 1
- Disease Characteristics, Treatment Patterns and Clinical Outcomes in Patients With Newly Diagnosed Unresectable Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) in ChinaCompletedNCT02458651
- Piloting the Feasibility of FLT-PET/CT Non-Small Cell Lung Cancer Managed With SBRTCompletedNCT02456246Not applicable
- Microwave Plus Chemotherapy Versus Chemotherapy for Advanced NSCLCStatus unknownNCT02455843Phase 3
- Study for Treatment With TH-4000 (Tarloxotinib) in Epidermal Growth Factor Receptor (EGFR) Mutant, T790M-negative Non-small Cell Lung Cancer (NSCLC) PatientsTerminatedNCT02454842Phase 2
- Binimetinib With Docetaxel in Treating Patients With Previously Treated, Stage IV Non-small Cell Lung CancerWithdrawnNCT02451865Phase 1
- Afatinib and Selumetinib in Advanced KRAS Mutant and PIK3CA Wildtype Non-small Cell Lung CancerStatus unknownNCT02450656Phase 1/2
- Icotinib as Adjuvant Therapy Compared With Standard Chemotherapy in Stage II-IIIA NSCLC With EGFR-mutationStatus unknownNCT02448797Phase 3
- Cohort of Non-small Cell Lung Cancer With Mutation of the Nord Pas de Calais (CB(NPC)²)CompletedNCT02448758
- Safety, Pharmacokinetic and Preliminary Efficacy Study of AC0010MA in Advanced Non Small Cell Lung CancerTerminatedNCT02448251Phase 1
- Marker Guided Breathhold Radiotherapy in NSCLCCompletedNCT02447900Phase 1
- Micro RNA Genetic Signature in NSCLC Egyptian PatientsCompletedNCT02445924
- Phase II Trial to Evaluate the Efficacy and Safety of HM61713 as the 1st-line NSCLC Anticancer TherapyCompletedNCT02444819Phase 2
- Safety Study of AMG 228 to Treat Solid TumorsTerminatedNCT02437916Phase 1
- Locally Invasive NSCLC Treated With NEo-Adjuvant Stereotactic Body RadioTherapy and REsectionStatus unknownNCT02433574Not applicable
- Vaccine Therapy and Pembrolizumab in Treating Patients With Solid Tumors That Have Failed Prior TherapyActive, not recruitingNCT02432963Phase 1
- Genomic Landscape of EGFR Mutant NSCLC Prior to Erlotinib and at the Time of Disease ProgressionTerminatedNCT02431169
- Chemotherapy of NSCLC With or Without IcotinibStatus unknownNCT02430974Phase 2
- Phase IB Study to Evaluate the Safety of Selinexor (KPT-330) in Combination With Multiple Standard Chemotherapy or Immunotherapy Agents in Patients With Advanced MalignanciesTerminatedNCT02419495Phase 1
- Mature Dendritic Cell Vaccination Against Unique Immunogenic Peptides in Patients With Non Small Cell Lung Cancer (NSCLC)WithdrawnNCT02419170Early Phase 1
- Stereotactic Ablative Radiotherapy for Oligometastatic Non-small Cell Lung CancerActive, not recruitingNCT02417662Not applicable
- Anticancer Activity of Nicotinamide on Lung CancerStatus unknownNCT02416739Phase 2/3
- Isolating and Testing Circulating Tumor DNA and Soluble Immune Markers During the Course of Treatment for Lung CancerCompletedNCT02410603
- Study of S-588410 After Adjuvant Chemotherapy for Completely Resected Non-small- Cell Lung CancerStatus unknownNCT02410369Phase 2
- Perfusion-Induced Hyperthermia for Metastatic CarcinomaCompletedNCT02409108Not applicable
- Icotinib With Concurrent Radiotherapy vs. Chemoradiotherapy in Non-small Cell Lung CancerStatus unknownNCT02407366Phase 2
- Individualized Treatment of Patients With Advanced NSCLC: Potential Application for Circulating Tumor Cells (CTC) Molecular and Phenotypical ProfilingCompletedNCT02407327
- Ph2 Nab-paclitaxel With Gemcitabine to Determine Efficacy in Advanced Non-squamous NSCLC.WithdrawnNCT02405910Phase 2
- TAURAS - T790 AURA ScreenFailure SOC Registry StudyTerminatedNCT02405247
- High Dose Icotinib in Advanced Non-small Cell Lung Cancer With EGFR 21 Exon MutationStatus unknownNCT02404675Phase 4
- Trial of PBF-509 and PDR001 in Patients With Advanced Non-small Cell Lung Cancer (NSCLC)CompletedNCT02403193Phase 1
- MPDL3280A and Stereotactic Ablative Radiotherapy in Patients With Non-small Cell Lung CancerTerminatedNCT02400814Phase 1
- Study of the Efficacy of SBRT on Unresectable Peripheral Primary TumorTerminatedNCT02400424Not applicable
- Comparison of Cost-effectiveness of Continuation Maintenance Therapy With Six Cycles of Pemetrexed Versus Pemetrexed Until Disease Progression for Metastatic Non-squamous Non-small-cell Lung CancerStatus unknownNCT02397239
- Study of Safety and Efficacy of Ceritinib in Combination With Nivolumab in Patients With ALK-positive Non-small Cell Lung CancerActive, not recruitingNCT02393625Phase 1